ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

DCCP Board Defers Two Concept Requests, Approves Sole Sources

October 22, 1982

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001

John & Florence Antione To Leave NCI for Jobs At Loma Linda Univ.

June 21, 1991

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Seer Data On Cancer Incidence Among Minorities Published

May 10, 1996